What is NMAD's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.07B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for NMAD?

P/E (TTM) is n/a and 52-week range is $3.12 to $7.70 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s NMAD figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for NMAD?

The company profile lists net income (TTM) near $-19M, EPS (TTM) near $-0.98 when available from the market-data feed. Figures are informational and may lag live markets.

Where is NOMAD Power Solutions, Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Boca Raton, Florida, US, 19M shares outstanding, ISIN US5393193017 when available from company profile and filing metadata.

Chartloom

Please enable JavaScript to continue using this application.

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The company is headquartered in Boca Raton, Florida and currently employs 3 full-time employees. The company went IPO on 2007-09-21. Its product consists of Voyager Eagle, Voyager Falcon, and Voyager Hawk. The company also continues to advance its life sciences portfolio through LIXTE Biotechnology and Liora Technologies, including the development of novel oncology therapeutics and medical technologies. The firm is focused on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100. LB-100 is being tested in clinical trials in Ovarian Clear Cell Carcinoma, Metastatic Colon Cancer, and Advanced Soft Tissue Sarcoma. Liora Technologies provides Linac for Image Guided Hadron Therapy (LiGHT) system technology, installation support, ongoing maintenance, software upgrades, and clinical/technical training.

Employees

Website

www.nomadpower.com

IPO

2007-09-21

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)